963.30
-2.85(-0.29%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3065
First IPO Date
June 26, 2002
| Name | Title | Pay | Year Born |
| Mr. Badree Komandur | MD & Group Chief Executive Officer | 58.1M | 1972 |
| Mr. Aditya Arun Kumar | Executive Director of Business Development & Director | 16.2M | N/A |
| Mr. Arun Kumar Pillai B.Com. | Founder & Non-Executive Chairperson | 90M | 1961 |
| Mr. C. K. Sundar | Executive Vice President of Operations | 0 | N/A |
| Mr. Kevin P. Cook | Senior Vice President of Strides Pharma Inc. | 0 | N/A |
| Mr. P. V. S. Ramaraju | Chief Operating Officer | 0 | N/A |
| Ms. Manjula Ramamurthy | Compliance Officer & Company Secretary | 0 | N/A |
| Ms. Surabhi Loshali | Group Chief Human Resource Officer | 0 | 1980 |
| Sormistha Ghosh | Group General Counsel, Chief Risk Officer & Chief Sustainability Officer | 0 | N/A |
| Mr. Vikesh Kumar | Group Chief Financial Officer & Chief Investor Relations Officer | 0 | 1985 |
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.